Literature DB >> 16377963

Effects of 5-HT2A receptor stimulation on the discrimination of durations by rats.

Karim Asgari1, Stephanie Body, Victoria K Bak, Zhong-Qi Zhang, Jonathan F Rickard, Jeffrey C Glennon, Kevin C F Fone, Christopher M Bradshaw, Elemér Szabadi.   

Abstract

We recently found that rats' ability to discriminate durations of exteroceptive stimuli is disrupted by the non-selective 5-HT receptor agonist quipazine. Ketanserin reversed this effect, suggesting that the effect may be mediated by 5-HT2A receptors. Here, we report that the 5-HT2A/2C receptor agonist 2,5-dimethoxy-4-iodoamphetamine (DOI) also disrupts temporal discrimination, and that this effect can be reversed by ketanserin and the highly selective 5-HT2A receptor antagonist (+/-)2,3-dimethoxyphenyl-1-[2-(4-piperidine)-methanol] (MDL-100907). Twenty rats were trained to discriminate durations in a discrete-trials psychophysical procedure. In each 50-s trial, a light was presented for t seconds, following which two levers (A and B) were presented. A response on A was reinforced if t < 25 s, and a response on B if t > 25 s. Logistic psychometric curves were fitted to the proportional choice of B (%B) for derivation of timing indices [T50: time corresponding to %B = 50; Weber fraction: (T75-T25)/2T50, where T75 and T25 are times corresponding to %B = 75 and 25, respectively]. DOI 0.25 mg kg (subcutaneous) significantly increased the Weber fraction and tended to increase T50. Ketanserin 2 mg kg (subcutaneous) did not alter either parameter, but completely antagonized the effects of DOI. Similarly, MDL-100907 0.5 and 1 mg kg (intraperitoneal) did not affect performance, but completely antagonized the effects of DOI. The results indicate that the mixed 5-HT2A/2C receptor agonist DOI disrupts temporal discrimination via stimulation of 5-HT2A receptors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16377963     DOI: 10.1097/01.fbp.0000189810.69425.89

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  12 in total

Review 1.  Neuroanatomical and neurochemical substrates of timing.

Authors:  Jennifer T Coull; Ruey-Kuang Cheng; Warren H Meck
Journal:  Neuropsychopharmacology       Date:  2010-07-28       Impact factor: 7.853

2.  Impulsive responding on the peak-interval procedure.

Authors:  Matthew S Matell; George S Portugal
Journal:  Behav Processes       Date:  2006-10-04       Impact factor: 1.777

3.  Effects of d-amphetamine and DOI (2,5-dimethoxy-4-iodoamphetamine) on timing behavior: interaction between D1 and 5-HT2A receptors.

Authors:  S Body; T H C Cheung; G Bezzina; K Asgari; K C F Fone; J C Glennon; C M Bradshaw; E Szabadi
Journal:  Psychopharmacology (Berl)       Date:  2006-10-19       Impact factor: 4.530

4.  The effect of reduced dopamine D4 receptor expression in the 5-choice continuous performance task: Separating response inhibition from premature responding.

Authors:  Jared W Young; Susan B Powell; Christine N Scott; Xianjin Zhou; Mark A Geyer
Journal:  Behav Brain Res       Date:  2011-03-31       Impact factor: 3.332

5.  Serotonin 1B receptor effects on response inhibition are independent of inhibitory learning.

Authors:  Stephanie S Desrochers; Katherine M Nautiyal
Journal:  Neurobiol Learn Mem       Date:  2021-12-12       Impact factor: 2.877

Review 6.  Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.

Authors:  Adam L Halberstadt
Journal:  Behav Brain Res       Date:  2014-07-15       Impact factor: 3.332

7.  Effect of 5-HT2A and 5-HT2C receptors on temporal discrimination by mice.

Authors:  Adam L Halberstadt; Ivan S Sindhunata; Kees Scheffers; Aaron D Flynn; Richard F Sharp; Mark A Geyer; Jared W Young
Journal:  Neuropharmacology       Date:  2016-03-25       Impact factor: 5.250

Review 8.  Psychedelics.

Authors:  David E Nichols
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

Review 9.  Serotonergic hallucinogens as translational models relevant to schizophrenia.

Authors:  Adam L Halberstadt; Mark A Geyer
Journal:  Int J Neuropsychopharmacol       Date:  2013-08-13       Impact factor: 5.176

10.  Hallucinations Under Psychedelics and in the Schizophrenia Spectrum: An Interdisciplinary and Multiscale Comparison.

Authors:  Pantelis Leptourgos; Martin Fortier-Davy; Robin Carhart-Harris; Philip R Corlett; David Dupuis; Adam L Halberstadt; Michael Kometer; Eva Kozakova; Frank LarØi; Tehseen N Noorani; Katrin H Preller; Flavie Waters; Yuliya Zaytseva; Renaud Jardri
Journal:  Schizophr Bull       Date:  2020-12-01       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.